Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 28:13:1628525.
doi: 10.3389/fped.2025.1628525. eCollection 2025.

Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report

Affiliations
Case Reports

Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report

Mengting Ma et al. Front Pediatr. .

Abstract

A 2-year-old patient was admitted to our hospital with hepatosplenomegaly as the prominent clinical feature. Peripheral blood analysis during hospitalization revealed trilineage cytopenia. Bone marrow cytology examination demonstrated abundant suspected Gaucher cells. Full-spine MRI exhibited widening of the distal femoral metaphysis with an "Erlenmeyer flask deformity." Subsequent enzymatic and genetic evaluations for Gaucher disease (GD) confirmed reduced β-glucocerebrosidase (GBA) activity, significantly elevated glucosylsphingosine (Lyso-Gb1) levels, and a homozygous missense mutation in the GBA gene c. 1448T>C(p.Leu483Pro). Genetic testing of the parents revealed both were heterozygous carriers of the same mutationc. 1448T>C(p.Leu483Pro), confirming the diagnosis of GD in the child with an autosomal recessive inheritance pattern. GD typically presents in childhood with hepatosplenomegaly, anemia, and thrombocytopenia. Given its rarity and nonspecific clinical manifestations, bone marrow cytology and imaging studies may provide diagnostic clues, but definitive diagnosis requires confirmation through β-glucocerebrosidase activity assays and genetic testing. Enzyme replacement therapy (ERT) is currently the primary treatment modality. The child is receiving regular intravenous infusions of imiglucerase at our hospital.

Keywords: Gaucher disease; Mendelian inheritance; genetic testing; rare disease; β-glucocerebrosidase.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Wright-Giemsa stain, ×1,000: Gaucher cells. (B) Glycogen stain, ×1,000: positive Gaucher cells. (C) iron stain, ×1,000: positive Gaucher cells (black arrows) and negative Gaucher cells (red arrows).
Figure 2
Figure 2
(A) MRI-T2WI image demonstrated diffusely decreased signal intensity in the vertebral bodies. (B) MRI-T1WI image demonstrated diffusely decreased signal intensity in the vertebral bodies. (C) Bilateral femoral MRI demonstrated metaphyseal widening of the distal femora with flask-shaped morphological alterations (white arrow).

Similar articles

  • Enzyme replacement and substrate reduction therapy for Gaucher disease.
    Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, Cox TM. Shemesh E, et al. Cochrane Database Syst Rev. 2015 Mar 27;2015(3):CD010324. doi: 10.1002/14651858.CD010324.pub2. Cochrane Database Syst Rev. 2015. PMID: 25812601 Free PMC article.
  • Beta-Thalassemia.
    Langer AL. Langer AL. 2000 Sep 28 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Sep 28 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301599 Free Books & Documents. Review.
  • Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.
    Zhang JH, Chen H, Ruan DD, Chen Y, Zhang L, Gao MZ, Chen Q, Yu HP, Wu JY, Lin XF, Fang ZT, Zheng XL, Luo JW, Liao LS, Li H. Zhang JH, et al. Ann Hematol. 2024 May;103(5):1765-1774. doi: 10.1007/s00277-024-05710-2. Epub 2024 Mar 20. Ann Hematol. 2024. PMID: 38509388
  • COL1A1- and COL1A2-Related Osteogenesis Imperfecta.
    Rodriguez Celin M, Steiner RD, Basel D. Rodriguez Celin M, et al. 2005 Jan 28 [updated 2025 May 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2005 Jan 28 [updated 2025 May 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301472 Free Books & Documents. Review.
  • Sickle Cell Disease.
    Bender MA, Carlberg K. Bender MA, et al. 2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301551 Free Books & Documents. Review.

References

    1. Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov Med. (2012) 14(77):273–81. - PMC - PubMed
    1. Cox TM. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis. (2001) 24:106–21. discussion 87–8. 10.1023/a:1012496514170 - DOI - PubMed
    1. Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. (2008) 372(9645):1263–71. 10.1016/S0140-6736(08)61522-6 - DOI - PubMed
    1. Di Costanzo M, de Paulis N, Cannalire G, Morelli N, Biasucci G. Pediatric Gaucher disease type 3 presenting with oculomotor apraxia: a case report. Children (Basel). (2024) 11(8):960. 10.3390/children11080960 - DOI - PMC - PubMed
    1. Weinreb NJ, Goker-Alpan O, Kishnani PS, Longo N, Burrow TA, Bernat JA, et al. The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here? Mol Genet Metab. (2022) 136(1):4–21. 10.1016/j.ymgme.2022.03.001 - DOI - PubMed

Publication types

LinkOut - more resources